TNFSF10 and cholangiocarcinoma: It has been established that cancer cells including CCA cell lines can develop resistance to TRAIL-induced apoptosis (47), with TRAIL-signaling instead contrarily inducing a tumor promoting inflammatory secretome, suggested to affect the tumor microenvironment (48).